Bain Capital Public Equity Management Ii, LLC Cytokinetics Inc Transaction History

Bain Capital Public Equity Management Ii, LLC

$1.99 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $2.41 Million - $3.47 Million	-70,929 Reduced 17.22%	340,926 $13.4 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $2.1 Million - $3.25 Million	70,583 Added 20.68%	411,855 $15.2 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $10.7 Million - $14.4 Million	-310,341 Reduced 47.63%	341,272 $15.6 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $7.13 Million - $13.7 Million	384,347 Added 143.81%	651,613 $23.3 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $3.68 Million - $5.02 Million	185,900 Added 228.47%	267,266 $5.29 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $1.51 Million - $2.09 Million	81,366 New	81,366 $1.89 Million

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$720 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$577 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$476 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$382 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$317 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Account